Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) - Total Assets
Based on the latest financial reports, Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) holds total assets worth $204.83 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See how leveraged is Oaktree Acquisition Corp. III Life Scien's balance sheet to measure how much of total assets are equity-financed.
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share - Total Assets Trend (2024–2025)
This chart illustrates how Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's total assets have evolved over time, based on quarterly financial data. Check OACC operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share - Asset Composition Analysis
Current Asset Composition (December 2025)
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's total assets of $204.83 Million consist of 0.8% current assets and 99.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.7% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2024–2025)
This chart illustrates how Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Oaktree Acquisition Corp. III Life Scien (OACC) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's current assets represent 0.8% of total assets in 2025, a decrease from 0.8% in 2024.
- Cash Position: Cash and equivalents constituted 0.7% of total assets in 2025, up from 0.7% in 2024.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2024.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Competitors by Total Assets
Key competitors of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Highview Merger Corp. Class A Ordinary Share
NASDAQ:HVMC
|
USA | $234.70 Million |
|
Cantor Equity Partners IV, Inc. Class A Ordinary Shares
NASDAQ:CEPF
|
USA | $460.83 Million |
|
Siddhi Acquisition Corp Class A Common stock
NASDAQ:SDHI
|
USA | $289.04 Million |
|
OneIM Acquisition Corp. Class A Ordinary Shares
NASDAQ:OIM
|
USA | $290.53 Million |
|
Titan Acquisition Corp
NASDAQ:TACH
|
USA | $283.89 Million |
|
K&F Growth Acquisition Corp. II Unit
NASDAQ:KFIIU
|
USA | $300.60 Million |
|
Andretti Acquisition Corp. II Class A Ordinary Shares
NASDAQ:POLE
|
USA | $246.69 Million |
|
Aldel Financial II Inc. Class A Ordinary Shares
NASDAQ:ALDF
|
USA | $239.11 Million |
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.87 | 1.40 | 2.14 |
| Quick Ratio | 0.87 | 1.40 | 2.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-207.95K | $423.96K | $831.00K |
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share - Advanced Valuation Insights
This section examines the relationship between Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.33 |
| Latest Market Cap to Assets Ratio | 1.04 |
| Asset Growth Rate (YoY) | 4.0% |
| Total Assets | $203.11 Million |
| Market Capitalization | $210.69 Million USD |
Valuation Analysis
Above Book Valuation: The market values Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's assets above their book value (1.04x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's assets grew by 4.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (2024–2025)
The table below shows the annual total assets of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share from 2024 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $203.11 Million | +4.03% |
| 2024-12-31 | $195.25 Million | -- |
About Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in … Read more